Biological Conversion of Methane to Liquid Fuels

Introduction

Methane (CH₄), the primary component of natural gas and a potent greenhouse gas, is widely available from sources like natural gas reservoirs, biogas, landfills, and agriculture. While its combustion is a major energy source, direct conversion of methane into liquid fuels offers a cleaner, value-added alternative—especially when done biologically.

The biological conversion of methane involves using specialized microbes called methanotrophs to oxidize CH₄ into methanol, organic acids, and hydrocarbons under mild conditions. This approach avoids the harsh temperatures and pressures of conventional methods, enabling carbon-efficient, decentralized fuel production from methane-rich waste streams.

What Products Are Produced?

• Methanol – A key intermediate fuel and chemical
• Bioethanol & Butanol – Through extended microbial pathways
• Lipids and hydrocarbons – For renewable diesel and SAF
• Organic acids – Acetate, lactate, succinate
• Single-cell protein – Microbial biomass for animal feed

Pathways and Production Methods

1. Methanotrophic Oxidation

• Type I and Type II methanotrophs oxidize methane using methane monooxygenase (MMO)
• CH₄ → Methanol → Formaldehyde → Biomass or metabolites

2. Engineered Metabolic Pathways

• Redirect carbon flow toward fuel molecules using synthetic biology
• Methanol → Ethanol, butanol, or fatty acids
• Methane → Acetyl-CoA → Lipids for biofuel upgrading

3. Two-Stage Systems

• Stage 1: Methanotroph converts CH₄ to methanol or acids
• Stage 2: Secondary microbes convert intermediates to biofuels

4. Gas Fermentation Reactors

• Bubble column or membrane reactors designed for gas–liquid mass transfer
• Optimization of O₂/CH₄ ratios and pH for methanotroph performance

Catalysts and Key Tools Used

Microbial Hosts

• Methylococcus capsulatus, Methylosinus trichosporium – Native methane oxidizers
• Engineered E. coli, Pichia pastoris – Expressing MMO enzymes
• Methanotrophic consortia for improved conversion and tolerance

Key Enzymes:

• Methane Monooxygenase (MMO) – Converts CH₄ to methanol
• Formaldehyde dehydrogenase, Acetyl-CoA synthase – For downstream fuel synthesis

Reactor Technology:

• Pressurized fermentation systems for gas solubility
• Continuous flow bioreactors with microbubble sparging
• Immobilized microbial beds for process stability

Case Study: Calysta’s FeedKind® Platform for Methane Bioconversion (USA)

Highlights

• Uses Methylococcus capsulatus to convert CH₄ into single-cell protein (SCP)
• SCP used as animal feed additive and aquaculture supplement
• Methanotrophic platform under development for fuel precursors

Timeline

• 2012 – Calysta founded for gas-to-protein technology
• 2017 – First FeedKind® plant operational in UK
• 2021 – JV with Adisseo in China for large-scale production
• 2024 – Expanding bioconversion research to include liquid fuel targets

Global and Indian Startups Working in This Area

Global

• Calysta (USA/UK) – CH₄ to SCP; expanding into fuels
• Industrial Microbes (USA) – Engineered microbes for CH₄-to-chemicals
• String Bio (India) – CH₄ to proteins and bioactives, entering fuel domain
• Mango Materials (USA) – CH₄ to PHA (bioplastics) with potential for energy integration

India

• String Bio (Bangalore) – Pioneer in methane bioutilization; exploring fuel routes
• IIT Madras & CSIR-NCL – R&D on methane-to-methanol and lipids
• TERI – Biogas valorization into fuel intermediates
• ONGC Energy Centre – Projects on methane valorization via bio and hybrid systems

Market and Demand

The biological methane conversion market is in an emerging phase, contributing to the broader bio-CNG, methanol economy, and low-carbon fuel sectors. The bio-methanol market alone is projected to grow from USD 350 million in 2023 to USD 1.2 billion by 2030, with a CAGR of ~18%.

Major End-Use Segments:

• Methanol for fuel blending and chemicals
• SAF precursors from methanol or lipids
• Single-cell oils for biodiesel
• Natural gas emission mitigation from landfills and agriculture
• On-site fuel generation at oil & gas fields

Key Growth Drivers

• Rising concern over methane as a GHG (28x CO₂ impact)
• Abundant sources: biogas, landfills, flare gas, shale gas
• Lower energy requirement than thermal routes
• Potential for modular, distributed fuel production
• Strong synergy with circular economy and carbon credit markets

Challenges to Address

• Low solubility of methane in aqueous systems
• MMO enzyme is oxygen-sensitive and difficult to express
• Low product titers and conversion rates
• Risk of cell toxicity from intermediates (formaldehyde, methanol)
• Need for scalable, gas-tight bioreactors with precise control

Progress Indicators

• 2010 – Engineered methanotrophs show methanol overproduction
• 2015 – First CH₄-to-SCP commercial plants launched
• 2019 – CH₄-to-lipid routes demonstrated in labs
• 2022 – India’s bio-methane roadmap includes biofuels
• 2024 – String Bio and partners begin trials for methane-derived fuel molecules

Biological methane-to-fuel technologies are at TRL 5–6, with pilot-scale operations in place for SCP and methanol; fuel-focused applications are advancing toward TRL 6 globally, and TRL 4–5 in India.

Conclusion

The biological conversion of methane to liquid fuels presents a sustainable, decentralized path for transforming methane-rich waste streams into clean, transportable energy. With advances in synthetic biology, bioreactor engineering, and metabolic control, this route could significantly contribute to methane mitigation and renewable fuel production.

As India scales up bio-CNG and methane recovery, biological conversion offers a strategic opportunity to tap local methane sources for high-value biofuels, aligning with national goals in climate action and energy security.

Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in